DXB 9.84% 55.0¢ dimerix limited

Dimerix (ASX: DXB) Discussion Thread, page-430

  1. 11,717 Posts.
    lightbulb Created with Sketch. 5939
    Phase III Interim Results ,,, Phase III is heavily monitored , haven't seen any major adverse effects , Phase III is generally How effective a Treatment is , its not really a Binary Outcome , Pass Fail, Go Stop etc ,,,
    When you have Physicians recommend that their Patients stay on a Medication ( a non regulated or approved Medication ) you know that there would be evidence that the medication has demonstrated "Patient Benefit"

    My main Holding here is averaging 9c so well exceeded my normal margin ,, I can see DXB surpassing 40c possibly 50c , I wont be here long after that as I'll be back over on BOT for the FDA Approval ,, plus I have a few near term opportunities in between ,,

    Great year for Biotech so far,,long may it continue NZT
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
55.0¢
Change
-0.060(9.84%)
Mkt cap ! $302.3M
Open High Low Value Volume
60.5¢ 61.0¢ 55.0¢ $2.309M 4.010M

Buyers (Bids)

No. Vol. Price($)
9 137019 55.0¢
 

Sellers (Offers)

Price($) Vol. No.
55.5¢ 22500 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.